Effects of TRPV2 on the Expression of PD-L1 and Its Binding Ability to PD-1 in Gastric Cancer.

Atsushi ShiozakiTomoyuki FukamiHiroki ShimizuToshiyuki KosugaMichihiro KudouKenichi TakemotoKeita KatsuraharaKeiji NishibeppuTakuma OhashiTomohiro AritaHirotaka KonishiShuhei KomatsuTakeshi KubotaHitoshi FujiwaraEigo Otsuji

Published in: Annals of surgical oncology (2023)

, indicating the potential of TRPV2 as a biomarker and target of immune checkpoint blockage for GC.

Keyphrases

neuropathic pain
poor prognosis
binding protein
spinal cord
dna binding
gas chromatography
risk assessment
mass spectrometry
transcription factor
high resolution